AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden · Delayed Price · Currency is SEK 6.96
-0.14 (-1.97%)
Oct 13, 2026, 11:39 AM CET
AlzeCure Pharma AB Market Cap
AlzeCure Pharma AB has a market cap or net worth of 959.77 million as of October 12, 2026. It is the 25,561st most valuable company in the world and the 312th biggest in Sweden. Its market cap has increased by 234.08% in one year.
Market Cap
959.77M
Enterprise Value
948.28M
Revenue
97.33M
Global Rank
Country Rank
#312 Sweden
PE Ratio
26.30
ChartMarket Cap Chart
Since November 28, 2018, AlzeCure Pharma AB's market cap has increased from 415.42M to 959.77M, an increase of 131.03%. That is a compound annual growth rate of 11.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 959.77M | 317.60% |
| Dec 30, 2025 | 229.83M | 126.34% |
| Dec 30, 2024 | 101.54M | -47.41% |
| Dec 29, 2023 | 193.09M | -24.88% |
| Dec 30, 2022 | 257.04M | 14.39% |
| Dec 30, 2021 | 224.71M | -34.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioInvent International AB | 1.52B |
| Genovis AB (publ.) | 1.36B |
| Flerie AB | 1.36B |
| Saniona AB | 1.27B |
| Oncopeptides AB | 1.17B |
| Infant Bacterial Therapeutics AB | 996.89M |
| SynAct Pharma AB | 959.81M |
| Medivir AB | 921.08M |